If you have trouble viewing this email, read the online version.

One force driving the development of electric vertical-lift technology is coming from an unusual source: United Therapeutics, a U.S. biotechnology company that is working to increase the availability of lungs and other organs for transplant.

Led by CEO Martine Rothblatt, United Therapeutics (UT) is backing three different efforts to develop electric vertical-takeoff-and-landing (eVTOL) vehicles to meet a projected need for 1,000 organ-delivery aircraft by the end of the decade.

Access exclusive subscriber-only coverage on expected improvements and innovation in electric aircraft technology.

Plus every subscriber has access to our special annual issue, Aerospace & Defense 2021. Providing a predictive outlook on the global aerospace & defense industry and what you need to know for the year ahead.

Subscribe today and receive all of this plus exclusive online access at aviationweek.com

SUBSCRIBE NOW

Credit: Beta Technologies

Periodically, Aviation Week & Space Technology will inform you of special shows, products and other offers that we believe you will find helpful in your business or career. To STOP receiving promotional e-mails from Aviation Week & Space Technology, please click here.

To STOP receiving ALL promotional e-mails from Aviation Week Network, please click here.

Aviation Week Network | Informa | 605 Third Avenue, 22nd Floor, New York, NY 10158 | Privacy Policy